Melatonin activates cell death programs for the suppression of uterine leiomyoma cell proliferation
- 11 November 2019
- journal article
- research article
- Published by Wiley in Journal of Pineal Research
- Vol. 68 (1) , e12620
Abstract
The circadian nature of melatonin has a protective effect on the progression of female reproductive cancers, including breast and ovarian cancers. However, the effect of melatonin on the growth of uterine leiomyoma is still unclear. In this study, we found that the growth of uterine leiomyoma ELT3 cells was reduced by treatment with melatonin. Treatment with melatonin increased the distribution of sub‐G1 phase and increased DNA condensation in ELT3 cells. Melatonin‐induced apoptosis and autophagy cell death progression were observed in ELT3 cells. Melatonin exerts a highly selective effect on primary normal human uterine smooth muscle (UtSMC) cells. The UtSMC cell cycle was arrested by melatonin treatment through up‐regulation of p21, p27, and PTEN protein expression, but melatonin did not further promote apoptosis program activation. Melatonin reduced cell proliferation in ELT3 cells underlying the activation of melatonin MT1 and MT2 receptors, which in turn down‐regulated the Akt‐ERK1/2‐NFκB signaling pathway. Melatonin reduced ELT3 tumor growth in both xenograft and orthotopic uterine tumor mice models. The extracellular matrix of the tumor was also reduced by melatonin treatment. Taken together, these results suggest that melatonin potentially plays a role in suppression of uterine leiomyoma growth.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST106‐ 2320‐B‐038‐064‐MY3, MOST103‐2313‐B‐038‐003‐MY3, NSC102‐2313‐B‐038‐001)
- Council of Agriculture (106AS‐16.4.1‐ST‐a4, 107AS-13.4.1-ST-a6, 108AS-12.4.1-ST-a3)
This publication has 53 references indexed in Scilit:
- Sleep duration and endometrial cancer riskCancer Causes & Control, 2012
- Autophagy-deficient mice develop multiple liver tumorsGenes & Development, 2011
- Functional interplay between melatonin receptor-mediated antiproliferative signaling and androgen receptor signaling in human prostate epithelial cells: potential implications for therapeutic strategies against prostate cancerJournal of Pineal Research, 2011
- Melatonin signaling and cell protection functionThe FASEB Journal, 2010
- Autophagy and tumorigenesisFEBS Letters, 2009
- Combined Vascular Endothelial Growth Factor Receptor/Epidermal Growth Factor Receptor Blockade with Chemotherapy for Treatment of Local, Uterine, and Metastatic Soft Tissue SarcomaClinical Cancer Research, 2008
- Physiological effects of melatonin: Role of melatonin receptors and signal transduction pathwaysProgress in Neurobiology, 2008
- Circadian Disruption, Shift Work and the Risk of Cancer: A Summary of the Evidence and Studies in SeattleCancer Causes & Control, 2006
- Bcl-2 down-regulation causes autophagy in a caspase-independent manner in human leukemic HL60 cellsCell Death & Differentiation, 2000
- Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some, neoplasmsThe Journal of Pathology, 1990